KalVista Pharmaceuticals, Inc. (KALV)
16.16
-0.70
(-4.15%)
USD |
NASDAQ |
Dec 09, 16:00
16.14
-0.02
(-0.09%)
After-Hours: 20:00
KalVista Pharmaceuticals Shareholders Equity (Quarterly): 17.00M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | -387.89M |
| Revolution Medicines, Inc. | 1.597B |
| Silvergate Capital Corp. | -- |
| Perspective Therapeutics, Inc. | 242.22M |
| Electromed, Inc. | 44.74M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 339.93M |
| Total Liabilities (Quarterly) | 322.93M |
| Debt to Equity Ratio | 16.62 |
| Current Ratio | 7.216 |
| Net Debt Paydown Yield | -8.98% |